Skip to main content
Fig. 6 | Biology Direct

Fig. 6

From: A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma

Fig. 6

Assessment of the ability to predict therapeutic responses. (A-B) The results to show different responses to TACE between patients with different prognostic risks. (C-D) The results to show different responses to sorafenib between patients with different prognostic risks. (E) The result to show the TIDE scores of patients with different prognostic risks. (F) The expression of 4 common immune checkpoint genes between patients with different prognostic risks

Back to article page

Biology Direct

ISSN: 1745-6150

Contact us